Literature DB >> 19903767

Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells.

Likun Li1, Chengzhen Ren, Guang Yang, Alexei A Goltsov, Ken-ichi Tabata, Timothy C Thompson.   

Abstract

Caveolin-1 (cav-1) and the cancer-promoting growth factors vascular endothelial growth factor (VEGF), transforming growth factor beta1 (TGF-beta1), and fibroblast growth factor 2 (FGF2) are often found to be upregulated in advanced prostate cancer and other malignancies. However, the relationship between cav-1 overexpression and growth factor upregulation remains unclear. This report presents, to our knowledge, the first evidence that in prostate cancer cells, a positive autoregulatory feedback loop is established in which VEGF, TGF-beta1, and FGF2 upregulate cav-1, and cav-1 expression, in turn, leads to increased levels of VEGF, TGF-beta1, and FGF2 mRNA and protein, resulting in enhanced invasive activities of prostate cancer cells, i.e., migration and motility. Our results further show that cav-1-enhanced mRNA stability is a major mechanism underlying the upregulation of these cancer-promoting growth factors, and that PI3-K-Akt signaling is required for forming this positive autoregulatory feedback loop.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903767      PMCID: PMC3881562          DOI: 10.1158/1541-7786.MCR-09-0255

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  48 in total

Review 1.  Multiple functions of caveolin-1.

Authors:  Pingsheng Liu; Michael Rudick; Richard G W Anderson
Journal:  J Biol Chem       Date:  2002-08-19       Impact factor: 5.157

2.  Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.

Authors:  Guang Yang; Terry L Timme; Anna Frolov; Thomas M Wheeler; Timothy C Thompson
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

3.  TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing.

Authors:  Q H Song; V E Klepeis; M A Nugent; V Trinkaus-Randall
Journal:  Mol Pathol       Date:  2002-06

Review 4.  New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin.

Authors:  Robert D Koos; Armina A Kazi; Mark S Roberson; Jenny M Jones
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

Review 5.  Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate.

Authors:  David Danielpour
Journal:  Eur J Cancer       Date:  2005-04       Impact factor: 9.162

Review 6.  Clinical implications of circulating angiogenic factors in cancer patients.

Authors:  R T Poon; S T Fan; J Wong
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

7.  Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.

Authors:  L Li; G Yang; S Ebara; T Satoh; Y Nasu; T L Timme; C Ren; J Wang; S A Tahir; T C Thompson
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

Review 8.  Caveolin-1 in oncogenic transformation, cancer, and metastasis.

Authors:  Terence M Williams; Michael P Lisanti
Journal:  Am J Physiol Cell Physiol       Date:  2005-03       Impact factor: 4.249

Review 9.  The role of caveolin-1 in androgen insensitive prostate cancer.

Authors:  Vladimir Mouraviev; Likun Li; Salahaldin A Tahir; Guang Yang; Terry M Timme; Alexei Goltsov; Chengzhen Ren; Takefumi Satoh; Thomas M Wheeler; Michael M Ittmann; Brian J Miles; Robert J Amato; Dov Kadmon; Timothy C Thompson
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

Review 10.  VEGF and the quest for tumour angiogenesis factors.

Authors:  Napoleone Ferrara
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

View more
  22 in total

1.  Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1.

Authors:  Sudjit Luanpitpong; Siera Jo Talbott; Yon Rojanasakul; Ubonthip Nimmannit; Varisa Pongrakhananon; Liying Wang; Pithi Chanvorachote
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Guang Yang; Alexei A Goltsov; Chengzhen Ren; Shinji Kurosaka; Kohei Edamura; Richard Logothetis; Francesco J DeMayo; Patricia Troncoso; Jorge Blando; John DiGiovanni; Timothy C Thompson
Journal:  Mol Cancer Res       Date:  2011-12-05       Impact factor: 5.852

3.  Anti-caveolin-1 antibodies as anti-prostate cancer therapeutics.

Authors:  Shu-Ru Kuo; Salahaldin A Tahir; Sanghee Park; Timothy C Thompson; Scott Coffield; Arthur E Frankel; Jen-Sing Liu
Journal:  Hybridoma (Larchmt)       Date:  2012-04

4.  Pigment epithelium-derived factor inhibits caveolin-induced interleukin-8 gene expression and proliferation of human prostate cancer cells.

Authors:  Takanori Matsui; Ayako Ojima; Yuichiro Higashimoto; Junichi Taira; Kei Fukami; Sho-Ichi Yamagishi
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

5.  Absence of caveolin-1 alters heat shock protein expression in spontaneous mammary tumors driven by Her-2/neu expression.

Authors:  Daniel R Ciocca; F Darío Cuello-Carrión; Anthony L Natoli; Christina Restall; Robin L Anderson
Journal:  Histochem Cell Biol       Date:  2011-11-15       Impact factor: 4.304

6.  Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.

Authors:  Salahaldin A Tahir; Sanghee Park; Timothy C Thompson
Journal:  Cancer Biol Ther       Date:  2009-12-19       Impact factor: 4.742

7.  Estradiol, TGF-β1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration.

Authors:  Seong-Joon Park; Joong-Gook Kim; Nam Deuk Kim; Kwangmo Yang; Jae Woong Shim; Kyu Heo
Journal:  Oncol Lett       Date:  2016-01-15       Impact factor: 2.967

8.  Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis.

Authors:  Jia-Ming Liu; Si-Hang Cheng; Xiao-Xiao Liu; Chao Xia; Wei-Wen Wang; Xue-Lei Ma
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 9.  Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.

Authors:  Zeyad D Nassar; Michelle M Hill; Robert G Parton; Marie-Odile Parat
Journal:  Nat Rev Urol       Date:  2013-08-13       Impact factor: 14.432

10.  Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.

Authors:  Salahaldin A Tahir; Shinji Kurosaka; Ryuta Tanimoto; Alexei A Goltsov; Sanghee Park; Timothy C Thompson
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.